Amplitude Surgical SA
PAR:AMPLI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.7
3.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Amplitude Surgical SA
Amplitude Surgical SA
Capital Expenditures
Amplitude Surgical SA
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Capital Expenditures
-€18.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Capital Expenditures
-€490k
|
CAGR 3-Years
9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-8%
|
|
|
Biomerieux SA
PAR:BIM
|
Capital Expenditures
-€338.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Carmat SA
PAR:ALCAR
|
Capital Expenditures
-€4.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-30%
|
|
|
Biosynex SA
PAR:ALBIO
|
Capital Expenditures
-€9.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Visiomed Group SA
PAR:ALVMG
|
Capital Expenditures
-€2.6m
|
CAGR 3-Years
-120%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-23%
|
|
Amplitude Surgical SA
Glance View
Amplitude Surgical SAS engages in the manufacturing, marketing and design of orthopedic products. The company is headquartered in Valence, Auvergne-Rhone-Alpes and currently employs 460 full-time employees. The company went IPO on 2015-06-26. The firm offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. The company operates through ofab Orthopedie, a strategic industrial subcontractor
See Also
What is Amplitude Surgical SA's Capital Expenditures?
Capital Expenditures
-18.9m
EUR
Based on the financial report for Jun 30, 2024, Amplitude Surgical SA's Capital Expenditures amounts to -18.9m EUR.
What is Amplitude Surgical SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-3%
Over the last year, the Capital Expenditures growth was 2%. The average annual Capital Expenditures growth rates for Amplitude Surgical SA have been -26% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
